W Jenkins
Member of the Advisory Board
Management
Allecra
Spain
Biography
William Jenkins joined the pharmaceutical industry 25 years ago after a successful career in clinical medicine, medical research and as deputy of the UK’s Medicines Control Agency. His career within the industry has spanned many senior roles including Head of Worldwide Clinical Research at Glaxo and later at Ciba-Geigy. After the merger with Sandoz to create Novartis, William was Global Head of Medicine, Clinical Development & Regulatory Affairs. During his industry career William was responsible for managing the development of numerous blockbuster drugs such as Zofran, Imigran, Serevent, Diovan & Gleevec. Since 1999 he has been a consultant to the pharmaceutical industry & a member of several boards at companies achieving significant transactions including BTG, Tanox, Monogram Biosciences, Eurand, Evotec, Acambis, Glycart, Ablynx & Consort Medical as well as a chairman or member of several scientific advisory boards
Research Interest
Pharmacology
